Drug shortage: Ropivacaine Hydrochloride Injection (ROPIVACAINE HYDROCHLORIDE, NAROPIN)
FDA lists 49 presentations as Current. Availability: Unavailable (13), Limited Availability (2), Available (34). Reason: Demand increase for the drug; Delay in shipping of the drug. Companies: Somerset Therapeutics, LLC, Eugia US LLC, Fresenius Kabi USA, LLC, InfoRLife SA, Caplin Steriles, Ltd..
- Published by source
- 2018-03-23
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Somerset Therapeutics, LLC
- Products
- Ropivacaine Hydrochloride Injection ROPIVACAINE HYDROCHLORIDE NAROPIN
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- On backorder. Recovery: TBD. Check wholesalers for inventory
- Check wholesalers for inventory
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2018-03-23
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #875 | new | 2026-10-22 | 1325b9230734…18ed3d | 5424451580b1…c56df7 |
Chain head: #1076 8ad5adc30b9b…88ce20